3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
99
INDUSTRY
9
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
1
Thyroid Carcinoma, Anaplastic
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neurofibromatosis 1
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Hematologic Neoplasms
1
HIV Infected Patients With Cancer Treated by ICPi
1
Glioma
1
Fallopian Tube Neoplasms
1
Cystadenocarcinoma, Serous
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Drug Therapy
4
pembrolizumab
3
Thermography
2
Surveys and Questionnaires
2
Standard of Care
2
Quality of Life
2
Preoperative Exercise
2
Nivolumab
2
Moxibustion
2
Hematologic Tests
2
Cyclophosphamide
2
Chemoradiotherapy
2
vandetanib
1
sinovac COVID-19 vaccine
1
lenvatinib
1
ibrutinib
1
fludarabine
1
encorafenib
1
durvalumab
1
binimetinib
1
beta Carotene
1
avelumab
1
atezolizumab
1
Zoledronic Acid
1
Zinc
1
Vitamin E
1
Vascular Access Devices
1
Validation Studies as Topic
1
Urination
1
Ultraviolet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT04691284
2025-05-29
SCTMICROBIOM
National Cancer Institute, Slovakia
Phase NA
Recruiting
100 enrolled